DR. JEFFREY L HUNTER M.D. NPI 1528063369

NPI Details

DR. Jeffrey L Hunter, M.D. is an internal medicine in Winter Haven, FL with 30 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Jeffrey L Hunter, M.D. NPI is 1528063369. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT
Graduation Year:1996

The provider's business location address is:

120 BATES AVE SW
WINTER HAVEN, FL
ZIP 33880-953
Phone: (863) 288-0960
Fax: (863) 288-0963

The NPI 1528063369 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ldl cholesterol level (HCPCS:83721)
• Hemoglobin a1c level (HCPCS:83036)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood test, clotting time (HCPCS:85610)
• Bacterial colony count, urine (HCPCS:87086)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Vitamin d-3 level (HCPCS:82306)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• X-ray of chest, 2 views (HCPCS:71046)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Screening 3d breast mammography (HCPCS:77063)
• Screening mammography (HCPCS:77067)
• Folic acid level, serum (HCPCS:82746)
• Injection, regadenoson, 0.1 mg (HCPCS:J2785)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
• Ferritin (blood protein) level (HCPCS:82728)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Screening test for autoimmune disorder (HCPCS:86038)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Uric acid level, blood (HCPCS:84550)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Coronavirus vaccine 14 (HCPCS:91313)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Testosterone (hormone) level, total (HCPCS:84403)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Rheumatoid factor level (HCPCS:86431)
• Electrocardiogram (ecg) 2-day continuous (HCPCS:93225)
• Electrocardiogram (ecg) 2-day continuous with report (HCPCS:93226)
• Electrocardiogram (ecg) 2-day continuous with review by health care professional (HCPCS:93227)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Liver function blood test panel (HCPCS:80076)
• Mri scan of lower spinal canal without contrast (HCPCS:72148)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)

The enumeration date for this NPI number is 6/17/2005 and was last updated on 3/18/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.